Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.
The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).
The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems.
The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East.
The Company’s Product Portfolio and Services:
- Tablets and Capsules – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines.
- Oral Liquids and Syrups – Used for respiratory, pediatric, and digestive treatments.
- External Preparations – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatments.
- Ayurvedic and Herbal Products – Focused on natural wellness solutions for immunity, digestion, and general health.
As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.
Accretion Pharmaceuticals IPO – Details
| IPO Opening Date | 14 May 2025 |
| IPO Closing Date | 16 May 2025 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue Size: 29,46,000 Shares Worth ₹29.75 Crore Fresh Issue: 29,46,000 Shares Worth ₹29.75 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹96 – ₹101 per share |
| Market Lot | 1200 Shares |
| Min Order | 1200 Shares (1 Lot) |
| Listing At | NSE SME |
| Register | Kfin Technologies Limited |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Accretion Pharmaceuticals IPO – Date Schedule
| IPO Open Date | 14 May 2025 |
| IPO Close Date | 16 May 2025 |
| Basis of Allotment | 19 May 2025 |
| Initiation of Refund | 20 May 2025 |
| Credit of Shares to Demat Account | 20 May 2025 |
| IPO Listing Date | 21 May 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 16, 2025 |
Accretion Pharmaceuticals IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹1,21,200 |
| Retail (Max) | 1 | 1200 | ₹1,21,200 |
| HNI (Min) | 2 | 2400 | ₹2,42,400 |
Competitive Strengths
- Experienced Promoters and Management Team.
- Long-standing relationship with clients and suppliers.
- Focus on providing quality products.
- Management has built a supply chain and customer relations, creating goodwill and trust.
Company Promoters
- Mr. Mayur Popatlal Sojitra
- Mr. Harshad Nanubhai Rathod
- Mr. Vivek Ashok Kumar Patel
- Mr. Hardik Mukundbhai Prajapati
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2022 | 22.58 | 22.48 | 0.07 | 7.61 |
| 31 March 2023 | 29.53 | 29.39 | 0.10 | 8.47 |
| 31 March 2024 | 33.93 | 28.17 | 3.87 | 13.48 |
| 31 December 2024 | 35.74 | 28.56 | 5.23 | 13.79 |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 72.47% |
| ROCE | 36.73% |
| Debt/Equity | 2.52 |
| RoNW | 72.47% |
| PAT Margin | 11.51 |
| Price to Book Value | 7.55 |
| Pre IPO | Post IPO | |
| EPS (Rs) | 4.74 | 6.28 |
| P/E (x) | 21.29 | 16.08 |
Object Of The Issue
- Capital expenditure towards purchase of new equipment/ machineries, etc.
- Capital expenditure towards upgradation of existing manufacturing facility.
- Repayment/prepayme nt of certain borrowings availed by the Company.
- Funding working capital requirements.
- General corporate purposes.
Accretion Pharmaceuticals IPO Promoter Holding
| Pre Issue Share Holding | 100.00% |
| Post Issue Share Holding | 73.48% |
Accretion Pharmaceuticals IPO Prospectus
Company Contact Information
| Accretion Pharmaceuticals Limited 29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad Sanand, Phone: +91-97148 82929 Email: compliance@accretionpharma.com Website: https://accretionpharma.com/ |
Accretion Pharmaceuticals IPO Registrar
| Kfin Technologies Limited Phone: 04067162222, 04079611000 Email: apl.ipo@kfintech.com Website: https://kosmic.kfintech.com/ipostatus/ |
Accretion Pharmaceuticals IPO Lead Manager(s)
| 1. Jawa Capital Services Private Limited |
Accretion Pharmaceuticals IPO FAQs
| What is Accretion Pharmaceuticals IPO? Accretion Pharmaceuticals IPO is a SME IPO. The issue is priced at ₹96 to ₹101 per equity share. The IPO is to be listed on NSE SME. |
| When Accretion Pharmaceuticals IPO will open? The IPO is to open on 14 May 2025 for QIB, NII, and Retail Investors. |
| What is Accretion Pharmaceuticals IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| How to Apply the Accretion Pharmaceuticals IPO? You can apply Accretion Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Accretion Pharmaceuticals IPO through Angle One? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Accretion Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Angle One. |
| How to Apply the Accretion Pharmaceuticals IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Accretion Pharmaceuticals IPO“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Accretion Pharmaceuticals IPO through Upstox? Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Accretion Pharmaceuticals IPO”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox. |
| How to Apply the Accretion Pharmaceuticals IPO through IIFL? Log in to IIFL Application with your credentials. Select the IPO. You will see the IPO Name “Accretion Pharmaceuticals IPO“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with IIFL. |
| What is Accretion Pharmaceuticals IPO Size? Accretion Pharmaceuticals IPO size is ₹29.75 Crore. |
| What is the Accretion Pharmaceuticals IPO Price Band? Accretion Pharmaceuticals IPO Price Band is ₹96 to ₹101. |
| What is Accretion Pharmaceuticals IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 1200 Shares with ₹1,21,200 amount while the maximum bid is 1200 Shares with ₹1,21,200. |
| What is the Accretion Pharmaceuticals IPO Allotment Date? Accretion Pharmaceuticals IPO allotment date is 19 May 2025. |
| What is the Accretion Pharmaceuticals IPO Listing Date? Accretion Pharmaceuticals IPO listing date is 21 May 2025. The IPO is to be listed on NSE SME. |
